Lipid and Cholesterol Metabolism Flashcards

1
Q

Outline the pro-atherogenic effects of OX-LDL

A

Inhibits macrophage motility

Induces T-cell activation and VSMC division / differentiation

Toxic to endothelial cells

Enhances platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is cholesterol synthesised?

A

In the liver

Starts with acetyl-CoA

Requires HMG-CoA synthase and reductase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Recognise the main drug groups used in reducing LDL cholesterol

A

Statins = simvastatin

Cholesterol lipase inhibitors = ezetimibe

Nicotinic acid / niacin

Fibrates = fenofibrate

Resins = colestyramine

Omega-3 FA = omacor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Discuss statins

A

Inhibit cholesterol synthesis in hepatocytes = block HMG-CoA reductase

Increase clearance of IDL and LDL – make sure receptors are still valid

Decrease production of VLDL and LDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the indication for the use of statins?

A

CV risk prevention (CVD + DM)

Familial hypercholesterolaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the adverse side effects of statins?

A

Liver damage - increased transaminase levels

Myopathy – pains in joints and muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Name some secondary benefits of statin treatment

A

Anti-inflam

Plaque reduction

Improved endothelial cell function

Reduced thrombotic risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe fibric acid derivatives

A

Mechanism = increases prod of lipoprotein lipase = reduces TG prod, SMALL reduction in LDL

Indication = adjunctive to diet, hypertriglyceridemia

ADR = GI upset, myositis, abnormal LFTs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe nicotinic acid

A

Mechanism = inhib lipoprotein a synthesis = reduced VLDL, increases HDL

Indication = risk of coronary events

ADR = flushing (taken with aspirin), itching, headache, hepatotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe ezetimibe?

A

Mechanism = inhibits intestinal cholesterol absorption, increase hepatic LDL receptors

ADR = headache, abdo pain, diarrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe evolocumab

A

Monoclonal Ab

PCSK9 inhibitor = inhibits proprotein convertase

Treats primary hypercholesterolaemia or mixed dyslipidaemia as adjunct to diet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Recognise the potential for non-drug dietary approaches to lipid lowering

A

Good diet has great impact on TG

Plant sterols – yogurts, flora

Diet rich in = fish oils, fibres, vit C/E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

outline how to undertake a CV risk assessment

A

QRISK2

Age

Gender

Ethnicity

Postcode

Clinical info = smoking, DM, angina, CDK, AF, BP treatment, RA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Outline the NICE guidance pertaining to lipid-lowering drug prescribing

A

Statin - recommend as primary prevention of CVD for adults who have a 20% or greater 10 year risk of devel CVD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly